“…Defects in ribosome biogenesis can impair stem cell differentiation and lead to diseases collectively called ribosomopathies (Armistead and Triggs-Raine, 2014; Barlow et al, 2010; Brooks et al, 2014; Calo et al, 2018; Higa-Nakamine et al, 2012; Mills and Green, 2017). Protein synthesis often increases during stem cell differentiation (Sanchez et al, 2016; Teixeira and Lehmann, 2019; Zhang et al, 2014), and inhibiting translation by modulating Target of Rapamycin (TOR) activity blocks terminal differentiation of various stem cells (Martin et al, 2022; Neumüller et al, 2008; Sanchez et al, 2016; Sun et al, 2010; Zhang et al, 2014). Nevertheless, how ribosome levels and translation control differentiation remains’ incompletely understood.…”